Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$646M |
| 2 |
Tesla
TSLA
|
+$572M |
| 3 |
Broadcom
AVGO
|
+$521M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$478M |
| 5 |
lululemon athletica
LULU
|
+$400M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$861M |
| 3 |
Palantir
PLTR
|
+$730M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$576M |
| 5 |
NVIDIA
NVDA
|
+$443M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 94.35% |
| 2 | Technology | 1.74% |
| 3 | Consumer Discretionary | 0.9% |
| 4 | Financials | 0.71% |
| 5 | Communication Services | 0.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2951
CALL
Agios Pharmaceuticals
AGIO
$2B
| $10.7M | ﹤0.01% |
267,300
+207,300
| +346% | +$7.8M |
|
2952
Crinetics Pharmaceuticals
CRNX
$9B
| $10.7M | ﹤0.01% |
257,505
+129,841
| +102% | +$4.15M |
|
2953
CALL
iShares S&P 500 Value ETF
IVE
$50.2B
| $10.7M | ﹤0.01% |
51,900
-31,200
| -38% | -$6.27M |
|
2954
CALL
PVH
PVH
$3.51B
| $10.7M | ﹤0.01% |
127,900
-72,600
| -36% | -$5.7M |
|
|
SW
2955
CALL
Smurfit Westrock
SW
$25.4B
| $10.7M | ﹤0.01% |
251,500
+22,800
| +10% | +$1.03M |
|
2956
CALL
Vodafone
VOD
$37B
| $10.7M | ﹤0.01% |
922,900
+146,300
| +19% | +$1.67M |
|
2957
CALL
Madison Square Garden
MSGS
$9.4B
| $10.7M | ﹤0.01% |
47,100
+17,100
| +57% | +$3.51M |
|
2958
Casella Waste Systems
CWST
$5.98B
| $10.7M | ﹤0.01% |
112,685
+11,798
| +12% | +$1.19M |
|
2959
PUT
Revolution Medicines
RVMD
$44.7B
| $10.7M | ﹤0.01% |
228,300
+114,900
| +101% | +$4.5M |
|
2960
CALL
Diageo
DEO
$51.7B
| $10.7M | ﹤0.01% |
111,700
+19,400
| +21% | +$2.04M |
|
|
VSXY
2961
PUT
Victoria's Secret
VSXY
$7.08B
| $10.7M | ﹤0.01% |
392,500
-374,600
| -49% | -$8.41M |
|
2962
VSE Corp
VSEC
$6.05B
| $10.6M | ﹤0.01% |
64,056
-10,297
| -14% | -$1.57M |
|
|
DFDV
2963
CALL
DeFi Development Corp
DFDV
$157M
| $10.6M | ﹤0.01% |
764,940
+629,090
| +463% | +$10.5M |
|
2964
CALL
JPMorgan Equity Premium Income ETF
JEPI
$46.2B
| $10.6M | ﹤0.01% |
186,400
+165,300
| +783% | +$9.39M |
|
|
OS
2965
DELISTED
OneStream Inc
OS
| $10.6M | ﹤0.01% |
577,468
+564,967
| +4,519% | +$12.4M |
|
2966
BorgWarner
BWA
$13.1B
| $10.6M | ﹤0.01% |
242,081
+234,510
| +3,097% | +$9.37M |
|
|
APLS
2967
CALL
DELISTED
Apellis Pharmaceuticals
APLS
| $10.6M | ﹤0.01% |
469,000
-47,800
| -9% | -$1.11M |
|
2968
Live Nation Entertainment
LYV
$42.1B
| $10.6M | ﹤0.01% |
64,938
-4,169
| -6% | -$659K |
|
2969
CALL
Planet Fitness
PLNT
$4.02B
| $10.6M | ﹤0.01% |
102,200
-41,900
| -29% | -$4.45M |
|
2970
CALL
Clover Health Investments
CLOV
$2.26B
| $10.6M | ﹤0.01% |
3,463,600
+2,401,100
| +226% | +$6.86M |
|
2971
Cboe Global Markets
CBOE
$32.6B
| $10.6M | ﹤0.01% |
43,063
+11,970
| +38% | +$2.88M |
|
2972
PUT
Recursion Pharmaceuticals
RXRX
$1.79B
| $10.6M | ﹤0.01% |
2,162,100
+499,000
| +30% | +$2.62M |
|
2973
CoStar Group
CSGP
$13.2B
| $10.5M | ﹤0.01% |
125,035
+75,728
| +154% | +$6.69M |
|
|
FAZ
2974
CALL
Direxion Daily Financial Bear 3x ETF
FAZ
$87.9M
| $10.5M | ﹤0.01% |
260,600
+167,140
| +179% | +$7.16M |
|
2975
CALL
Canadian Imperial Bank of Commerce
CM
$104B
| $10.5M | ﹤0.01% |
131,900
-367,000
| -74% | -$27.6M |
|
Similar funds
Jeff Yass's Q3 2025 Portfolio in Review
As of Q3 2025, Jeff Yass held 14,336 positions worth $875B, up 22% from $720B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q3 2025 filing shows 1,794 new, 5,240 increased, 5,148 reduced and 2,105 closed positions. Its largest new stake was BitMine Immersion Technologies: 7,689,603 shares worth $399M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B.
By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, up from 94% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2025 buy was BitMine Immersion Technologies: 7,689,603 shares worth $399M.
- Jeff Yass added most to Meta Platforms (Facebook) in Q3 2025, an estimated $646M increase.
- Jeff Yass's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Jeff Yass fully exited iShares Core MSCI Total International Stock ETF in Q3 2025, selling an estimated $123M.
- Jeff Yass's ten largest holdings make up 24% of its $875B portfolio in Q3 2025.
- Jeff Yass opened 1,794 new positions and closed 2,105 in Q3 2025.
- Jeff Yass's portfolio value rose 22% quarter-over-quarter to $875B.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.